EICHOR
● Completed
Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults
Condition: Tourette Disorder · Sponsor: Emalex Biosciences Inc.
About this study
This Phase 3 multicenter study evaluates the maintenance of efficacy, safety and tolerability of ecopipam tablets in children, adolescents and adults in the treatment of Tourette's Disorder (TD). The study includes an open-label period followed by a double-blind, placebo-controlled, randomized withdrawal period.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (95)
| Harmonex Neuroscience Research | Dothan, Alabama, United States | — |
| Arkansas Children's Hospital | Little Rock, Arkansas, United States | — |
| Advanced Research Center | Anaheim, California, United States | — |
| CenExel CIT-IE | Bellflower, California, United States | — |
| Cortica Site Network | Glendale, California, United States | — |
| Amnova Clinical Research | Irvine, California, United States | — |
| Cortica Site Network - San Rafael | San Rafael, California, United States | — |
| Syrentis Clinical Research | Santa Ana, California, United States | — |
| Yale School of Medicine | New Haven, Connecticut, United States | — |
| University of Florida | Gainesville, Florida, United States | — |
| NW FL Clinical Research Group, LLC | Gulf Breeze, Florida, United States | — |
| Research in Miami Inc | Hialeah, Florida, United States | — |
+ 83 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05615220